S. Yawalkar

发表

Therapeutic effects of adding rimactane (rifampicin) 450 milligrams daily or 1200 milligrams once monthly in a single dose to dapsone 50 milligrams daily in patients with lepromatous leprosy.

J. Languillon, A. Mcdougall, S. Yawalkar, 1979, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

Desferrioxamine in acute iron poisoning

A. Donfrancesco, R. Rivers, M. Shannon, 1992, The Lancet.

Venereal disease of the anal region

S. Yawalkar, B. S. Kulkarni, R. Menda, 1971, Diseases of the colon and rectum.

Dermatopharmacologic investigations of halobetasol propionate in comparison with clobetasol 17-propionate.

J R Gibson, J. R. Gibson, S Yawalkar, 1991, Journal of the American Academy of Dermatology.

ONCE-MONTHLY RIFAMPICIN PLUS DAILY DAPSONE IN INITIAL TREATMENT OF LEPROMATOUS LEPROSY

J. Languillon, A. Mcdougall, S. Yawalkar, 1982, The Lancet.

Crotamiton Cream and Lotion in the Treatment of Infants and Young Children with Scabies

S. Yawalkar, D. Konstantinov, L. Stanoeva, 1979, The Journal of international medical research.

A Single Application of Crotamiton Lotion in the Treatment of Patients with Pediculosis Capitis

S. Yawalkar, I. Karačić, 1982, International journal of dermatology.

A double-blind, multicenter, parallel-group trial with 0.05% halobetasol propionate ointment versus 0.1% diflucortolone valerate ointment in patients with severe, chronic atopic dermatitis or lichen simplex chronicus.

N. Brunner, S. Yawalkar, 1991, Journal of the American Academy of Dermatology.

Treatment of Localized Vitiligo with Ulobetasol Cream

S. Yawalkar, Jin Peiying, Ye Gan-yun, 1990, International journal of dermatology.

A double-blind, multicenter comparison of 0.05% halobetasol propionate ointment and 0.05% clobetasol propionate ointment in patients with chronic, localized plaque psoriasis.

S. Yawalkar, R. Hartdegen, D. Presbury, 1991, Journal of the American Academy of Dermatology.

Halobetasol propionate cream by day and halobetasol propionate ointment at night for the treatment of pediatric patients with chronic, localized plaque psoriasis and atopic dermatitis.

G. Herz, S. Yawalkar, G. Blum, 1991, Journal of the American Academy of Dermatology.

A comparative, multicenter, double blind trial of 0.05% halobetasol propionate ointment and 0.1% betamethasone valerate ointment in the treatment of patients with chronic, localized plaque psoriasis.

S. Yawalkar, G. Blum, 1991, Journal of the American Academy of Dermatology.

A double-blind, multicenter comparison between 0.05% halobetasol propionate ointment and 0.05% betamethasone dipropionate ointment in chronic plaque psoriasis.

H. Mensing, S. Yawalkar, G. Korsukéwitz, 1991, Journal of the American Academy of Dermatology.

Double-blind, comparative clinical trials with halobetasol propionate cream in patients with atopic dermatitis.

S. Yawalkar, L. Schwerzmann, 1991, Journal of the American Academy of Dermatology.

A double-blind, multicenter trial of 0.05% halobetasol propionate ointment and 0.05% clobetasol 17-propionate ointment in the treatment of patients with chronic, localized atopic dermatitis or lichen simplex chronicus.

S. Yawalkar, B. Datz, 1991, Journal of the American Academy of Dermatology.

A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy.

A. Mcdougall, S. Yawalkar, D. Opromolla, 1981, International journal of leprosy and other mycobacterial diseases.

A Double‐blind Comparison Betweeen a New Trihalogenated Dermatocorticosteroid (Halometasone) Cream and Clobetasol 17‐propionate (Dermovate) Cream

M. Konzelmann, P. Schoenenberger, S. Yawalkar, 1982, The British journal of clinical practice.

Evaluation of halometasone cream in the treatment of paediatric patients with acute eczematous dermatoses.

S. Yawalkar, G. Blum, 1983, The Journal of international medical research.

[Comparative clinical trial of a new trihalogenated dermatocorticoid (halometasone) versus betamethasone dipropionate].

E. Weirich, S. Yawalkar, H. Dressler, 1983, Zeitschrift fur Hautkrankheiten.

The therapeutic effect of Sicorten® ointment in patients with vitiligo

C. Shao, S. Yawalkar, Y. Ganyun, 1985, The British journal of clinical practice.

Evaluation of treatment with Sicorten cream by day and Sicorten ointment at night in patients with chronic psoriasis.

S. Yawalkar, E. Feurman, 1986, Singapore medical journal.

Evaluation of halometasone ointment in the treatment of paediatric patients with chronic eczematous dermatoses.

E. Weirich, G. Herz, S. Yawalkar, 1983, The Journal of international medical research.

An overview of international clinical trials with halometasone ointment in chronic eczematous dermatoses.

S. Yawalkar, V. Macarol, C. Montanari, 1983, Journal of International Medical Research.

An overview of international clinical trials with halometasone cream.

S. Yawalkar, V. Macarol, C. Montanari, 1983, The Journal of international medical research.

Clinical evaluation on the long-term use of halometasone ointment in chronic eczema and psoriasis.

S. Yawalkar, H. Weitgasser, 1983, The Journal of international medical research.